Circadian catecholamine rhythms in people with normal and raised blood pressure
- unpicking the role of the sympathetic nervous
system
Chief Investigator
|
Institution
|
Dates
|
Funding Stream
|
Amount
|
Dr Nicholas Sunderland |
University of Bristol and University Hospitals Bristol NHS
Foundation Trust
|
30/10/2020 to 04/08/2021
|
Above and Beyond Spring 2020
|
£13,125.00 |
Summary
High blood pressure affects around a third of adults in the UK,
although many do not realise it. If high blood pressure goes
untreated, there is damage to important organs such as the heart,
brain, and kidneys. Prolonged high blood pressure can lead to
'heart failure' - a condition in which the heart is unable to pump
enough blood to meet the body's needs, making people breathless and
less able to exercise.
The sympathetic nervous system plays an important role in blood
pressure control and acts on the heart and blood vessels via the
catecholamine neurotransmitters. Normal blood pressure is typically
higher during the day-time and lower at night (the circadian
rhythm). Loss of night-time dipping and increased day-to-day
variability are associated with bad patient outcomes. Defining the
circadian rhythm of catecholamine release is crucial to
interpreting these observations and designing treatment strategies
to reduce cardiovascular events.
Until recently there has been no easy way to assess the
circadian rhythm of the sympathetic nervous system. However, new
techniques in analytical chemistry and the U-RHYTHM 24-hour tissue
hormone sampler device offer an opportunity to address this
problem.
We will compare the 24-hour tissue catecholamine levels in
participants with normal blood pressure and people with high blood
pressure, looking for differences in sympathetic nervous activity
which may be driving the high blood pressure. The findings will
form the basis of a further PHD fellowship application, where we
aim to assess how patient treatment regimens can be optimised based
on their individual 24-hour catecholamine profiles.